Financhill
Buy
56

OPGN Quote, Financials, Valuation and Earnings

Last price:
$24.7500
Seasonality move :
32.23%
Day range:
$24.7500 - $24.7500
52-week range:
$0.0000 - $34.0000
Dividend yield:
0%
P/E ratio:
61.89x
P/S ratio:
27.78x
P/B ratio:
24.54x
Volume:
110
Avg. volume:
6.4K
1-year change:
2420.88%
Market cap:
$249.3M
Revenue:
$5.2M
EPS (TTM):
$0.40

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
OPGN
-- -- -- -- --
LAB
Standard BioTools, Inc.
$18.5M -$0.03 -56.37% -70.93% $1.55
LUDG
Ludwig Enterprises, Inc.
-- -- -- -- --
MHTX
Manhattan Scientifics, Inc.
-- -- -- -- --
USAQ
QHSLab, Inc.
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
OPGN
$24.7500 -- $249.3M 61.89x $0.00 0% 27.78x
LAB
Standard BioTools, Inc.
$1.06 $1.55 $407.6M -- $0.00 0% 3.82x
LUDG
Ludwig Enterprises, Inc.
$0.0349 -- $5.7M -- $0.00 0% 58,635.39x
MHTX
Manhattan Scientifics, Inc.
$0.0000 -- $600 -- $0.00 0% --
USAQ
QHSLab, Inc.
$0.7349 -- $8.3M -- $0.00 0% 3.70x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
OPGN
16.9% -39,423.208 205167.16% 5.70x
LAB
Standard BioTools, Inc.
6.77% 0.460 6.26% 1.86x
LUDG
Ludwig Enterprises, Inc.
-144.65% 0.332 24.05% 0.00x
MHTX
Manhattan Scientifics, Inc.
-- 80.588 -- --
USAQ
QHSLab, Inc.
162.97% -1.352 73.75% 0.17x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
OPGN
-$48.1K -$702.2K 70.06% 89.47% -5625.96% -$333.3K
LAB
Standard BioTools, Inc.
$10.2M -$21.9M -13.22% -14.14% -92.14% -$1.7M
LUDG
Ludwig Enterprises, Inc.
-- -$371.4K -- -- -419868.12% -$139.1K
MHTX
Manhattan Scientifics, Inc.
-- -$160K -- -- -- -$17K
USAQ
QHSLab, Inc.
$475.6K $96.3K -35.74% -- 13.05% $2.6K

vs. Competitors

  • Which has Higher Returns OPGN or LAB?

    Standard BioTools, Inc. has a net margin of -5629.82% compared to 's net margin of 58.42%. 's return on equity of 89.47% beat Standard BioTools, Inc.'s return on equity of -14.14%.

    Company Gross Margin Earnings Per Share Invested Capital
    OPGN
    55.51% -$0.06 $12.2M
    LAB
    Standard BioTools, Inc.
    43.03% $0.05 $455.1M
  • What do Analysts Say About OPGN or LAB?

    has a consensus price target of --, signalling upside risk potential of 21.21%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.55 which suggests that it could grow by 46.23%. Given that Standard BioTools, Inc. has higher upside potential than , analysts believe Standard BioTools, Inc. is more attractive than .

    Company Buy Ratings Hold Ratings Sell Ratings
    OPGN
    0 0 0
    LAB
    Standard BioTools, Inc.
    1 2 0
  • Is OPGN or LAB More Risky?

    has a beta of -3,221.492, which suggesting that the stock is 322249.211% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.359, suggesting its more volatile than the S&P 500 by 35.922%.

  • Which is a Better Dividend Stock OPGN or LAB?

    has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OPGN or LAB?

    quarterly revenues are --, which are smaller than Standard BioTools, Inc. quarterly revenues of $23.8M. 's net income of -$608.7K is lower than Standard BioTools, Inc.'s net income of $13.9M. Notably, 's price-to-earnings ratio is 61.89x while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for is 27.78x versus 3.82x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OPGN
    27.78x 61.89x -- -$608.7K
    LAB
    Standard BioTools, Inc.
    3.82x -- $23.8M $13.9M
  • Which has Higher Returns OPGN or LUDG?

    Ludwig Enterprises, Inc. has a net margin of -5629.82% compared to 's net margin of -427991.3%. 's return on equity of 89.47% beat Ludwig Enterprises, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    OPGN
    55.51% -$0.06 $12.2M
    LUDG
    Ludwig Enterprises, Inc.
    -- -- -$1.4M
  • What do Analysts Say About OPGN or LUDG?

    has a consensus price target of --, signalling upside risk potential of 21.21%. On the other hand Ludwig Enterprises, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that has higher upside potential than Ludwig Enterprises, Inc., analysts believe is more attractive than Ludwig Enterprises, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OPGN
    0 0 0
    LUDG
    Ludwig Enterprises, Inc.
    0 0 0
  • Is OPGN or LUDG More Risky?

    has a beta of -3,221.492, which suggesting that the stock is 322249.211% less volatile than S&P 500. In comparison Ludwig Enterprises, Inc. has a beta of 2.693, suggesting its more volatile than the S&P 500 by 169.348%.

  • Which is a Better Dividend Stock OPGN or LUDG?

    has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ludwig Enterprises, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. pays -- of its earnings as a dividend. Ludwig Enterprises, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OPGN or LUDG?

    quarterly revenues are --, which are smaller than Ludwig Enterprises, Inc. quarterly revenues of --. 's net income of -$608.7K is lower than Ludwig Enterprises, Inc.'s net income of $31.3K. Notably, 's price-to-earnings ratio is 61.89x while Ludwig Enterprises, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for is 27.78x versus 58,635.39x for Ludwig Enterprises, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OPGN
    27.78x 61.89x -- -$608.7K
    LUDG
    Ludwig Enterprises, Inc.
    58,635.39x -- -- $31.3K
  • Which has Higher Returns OPGN or MHTX?

    Manhattan Scientifics, Inc. has a net margin of -5629.82% compared to 's net margin of --. 's return on equity of 89.47% beat Manhattan Scientifics, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    OPGN
    55.51% -$0.06 $12.2M
    MHTX
    Manhattan Scientifics, Inc.
    -- -$0.00 --
  • What do Analysts Say About OPGN or MHTX?

    has a consensus price target of --, signalling upside risk potential of 21.21%. On the other hand Manhattan Scientifics, Inc. has an analysts' consensus of -- which suggests that it could grow by 24999900%. Given that Manhattan Scientifics, Inc. has higher upside potential than , analysts believe Manhattan Scientifics, Inc. is more attractive than .

    Company Buy Ratings Hold Ratings Sell Ratings
    OPGN
    0 0 0
    MHTX
    Manhattan Scientifics, Inc.
    0 0 0
  • Is OPGN or MHTX More Risky?

    has a beta of -3,221.492, which suggesting that the stock is 322249.211% less volatile than S&P 500. In comparison Manhattan Scientifics, Inc. has a beta of 9.435, suggesting its more volatile than the S&P 500 by 843.464%.

  • Which is a Better Dividend Stock OPGN or MHTX?

    has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Manhattan Scientifics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. pays -- of its earnings as a dividend. Manhattan Scientifics, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OPGN or MHTX?

    quarterly revenues are --, which are larger than Manhattan Scientifics, Inc. quarterly revenues of --. 's net income of -$608.7K is lower than Manhattan Scientifics, Inc.'s net income of -$158K. Notably, 's price-to-earnings ratio is 61.89x while Manhattan Scientifics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for is 27.78x versus -- for Manhattan Scientifics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OPGN
    27.78x 61.89x -- -$608.7K
    MHTX
    Manhattan Scientifics, Inc.
    -- -- -- -$158K
  • Which has Higher Returns OPGN or USAQ?

    QHSLab, Inc. has a net margin of -5629.82% compared to 's net margin of 4.53%. 's return on equity of 89.47% beat QHSLab, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    OPGN
    55.51% -$0.06 $12.2M
    USAQ
    QHSLab, Inc.
    64.52% $0.00 $970.2K
  • What do Analysts Say About OPGN or USAQ?

    has a consensus price target of --, signalling upside risk potential of 21.21%. On the other hand QHSLab, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that has higher upside potential than QHSLab, Inc., analysts believe is more attractive than QHSLab, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OPGN
    0 0 0
    USAQ
    QHSLab, Inc.
    0 0 0
  • Is OPGN or USAQ More Risky?

    has a beta of -3,221.492, which suggesting that the stock is 322249.211% less volatile than S&P 500. In comparison QHSLab, Inc. has a beta of 0.516, suggesting its less volatile than the S&P 500 by 48.351%.

  • Which is a Better Dividend Stock OPGN or USAQ?

    has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. QHSLab, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. pays -- of its earnings as a dividend. QHSLab, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OPGN or USAQ?

    quarterly revenues are --, which are smaller than QHSLab, Inc. quarterly revenues of $737.1K. 's net income of -$608.7K is lower than QHSLab, Inc.'s net income of $33.4K. Notably, 's price-to-earnings ratio is 61.89x while QHSLab, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for is 27.78x versus 3.70x for QHSLab, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OPGN
    27.78x 61.89x -- -$608.7K
    USAQ
    QHSLab, Inc.
    3.70x -- $737.1K $33.4K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
42
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Sell
48
ZD alert for Mar 5

Ziff Davis, Inc. [ZD] is up 3.64% over the past day.

Sell
36
PSIX alert for Mar 5

Power Solutions International, Inc. [PSIX] is down 1.4% over the past day.

Buy
54
TREE alert for Mar 5

LendingTree, Inc. [TREE] is up 1.11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock